Skip to Main Content

Paper Details

Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections.
Br J Ophthalmol
14
2021
Author NameAffiliation
Richard GaleYork Teaching Hospital NHS Foundation Trust
Richard GaleUniversity of York
Maria PikoulaInstitute of Health Informatics, University College London
Aaron LeeMoorfields Eye Hospital NHS Foundation Trust
Spiros DenaxasInstitute of Health Informatics, University College London
Catherine EganMoorfields Eye Hospital
Adnan TufailMoorfields Eye Hospital NHS Foundation Trust
Paul TaylorInstitute of Health Informatics, University College London
  • 1 - 8

Datasets

Release 1.2